@article{3b28a8ccd85b43ccafbf6585a7eda2ca,
title = "In Reply to {\textquoteleft}Response to the KDOQI US Commentary on the 2018 KDIGO Hepatitis C Guideline{\textquoteright}",
author = "{KDOQI HCV Commentary Work Group} and Reese, {Peter P.} and Bloom, {Roy D.} and David Roth",
note = "Funding Information: Dr Reese reports investigator-initiated grants from Merck and AbbVie to the University of Pennsylvania to support research on transplantation of HCV-infected organs into uninfected recipients, followed by antiviral treatment. Dr Roth has been an advisor to Merck and AbbVie. Dr Bloom declares that he has no relevant financial interests. Received August 3, 2020. Accepted August 5, 2020, after editorial review by a Deputy Editor.",
year = "2021",
month = jan,
doi = "10.1053/j.ajkd.2020.08.001",
language = "English (US)",
volume = "77",
pages = "152--153",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "1",
}